Jump to section
To power the future of primary care with AI diagnostics, world-class specialists, and comprehensive cloud data infrastructure.
38% employee growth in 12 months
Today, more than two-thirds of the global population lacks acccess to basic radiology services. In regions where medical staff are scarce, artifical intelligence offers a powerful tool to bridge that gap. Imagen is harnessing this potential with its technology designed to cut radiology error rates and speed up x-ray analysis. And long term, the company hopes to dsignificantly reduce radiology costs, for better are globally.
Imagen Technologies takes its place in a competitive global artificial intelligence diagnostics market, which is expected to reach a value of $1.7B by 2033.
The company's OsteoDetect software made history as the first FDA-approved tool to analyze wrist x-rays using AI. In February 2021, it raised $51M in Series C funding - bringing total investment to $35M since 2015. With this backing, the company is expanding both its product lineup and its team.
Kirsty
Company Specialist at Welcome to the Jungle
Feb 2021
$51m
SERIES C
Sep 2018
$40m
SERIES B
This company has top investors
Robert Lindsey
(Co-Founder & CTO)PhD from University of Colorado in Computer Science. Deep Learning Consultant and Research scientist at Boulder Analytics and Sensory Inc. respectively.
Alexander Dresner
(Co-Founder & CEO)Investment Manager for Bridgewater Associates and Value Analyst at the Hospital of Special Surgery.
Software Engineering
Operations & Strategy